Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

NCT00882258 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids

Interventions

DRUG: 12.5 mg Proellex
DRUG: 25 mg Proellex
DRUG: Placebo

Sponsor

Repros Therapeutics Inc.